Reviewing Akers Biosciences Inc. (AKER)’s and Microbot Medical Inc. (NASDAQ:MBOT)’s results

As Medical Instruments & Supplies companies, Akers Biosciences Inc. (NASDAQ:AKER) and Microbot Medical Inc. (NASDAQ:MBOT) are our subject to compare. And more specifically their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation.

Earnings and Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Akers Biosciences Inc. 2.32M 5.76 11.03M -3.09 0.00
Microbot Medical Inc. N/A 0.00 6.70M -2.40 0.00

Table 1 showcases the gross revenue, earnings per share (EPS) and valuation of Akers Biosciences Inc. and Microbot Medical Inc.

Profitability

Table 2 provides us Akers Biosciences Inc. and Microbot Medical Inc.’s return on assets, net margins and return on equity.

Net Margins Return on Equity Return on Assets
Akers Biosciences Inc. -475.43% -123.5% -98.5%
Microbot Medical Inc. 0.00% -77.8% -73.1%

Risk & Volatility

Akers Biosciences Inc. is 254.00% more volatile than S&P 500 due to its -1.54 beta. Microbot Medical Inc.’s 76.00% less volatile than S&P 500 volatility due to the company’s 0.24 beta.

Liquidity

Akers Biosciences Inc. has a Current Ratio of 3.4 and a Quick Ratio of 3.1. Competitively, Microbot Medical Inc.’s Current Ratio is 12.3 and has 12.3 Quick Ratio. Microbot Medical Inc.’s better ability to pay short and long-term obligations than Akers Biosciences Inc.

Insider & Institutional Ownership

The shares of both Akers Biosciences Inc. and Microbot Medical Inc. are owned by institutional investors at 11% and 15.4% respectively. 0.05% are Akers Biosciences Inc.’s share held by insiders. Insiders Comparatively, held 37.85% of Microbot Medical Inc. shares.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Akers Biosciences Inc. -12.58% -47.54% -35.34% -63.5% -63.89% 23.13%
Microbot Medical Inc. 11.33% -58.01% -67.64% -84.36% -87.86% -87.27%

For the past year Akers Biosciences Inc. had bullish trend while Microbot Medical Inc. had bearish trend.

Summary

Microbot Medical Inc. beats Akers Biosciences Inc. on 6 of the 9 factors.

Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States and internationally. The company’s marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. Its marketed products also include PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol ‘Check’, a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek, a breath test for oxidative stress using the Lync reader and digital app. The company’s pipeline products comprise Breath Diabetic Ketoacidosis, a disposable breath ketone device for diabetic monitoring; Breath PulmoHealth ‘Check’, a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; PIFA PLUSS Chlamydia, a rapid test for sexually transmitted diseases; and BreathScan KetoChek, a breath test for ketosis using the Lync reader and digital app. Akers Biosciences, Inc. was founded in 1989 and is headquartered in Thorofare, New Jersey.

Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops next generation micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The companyÂ’s product candidates include Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and TipCAT, a semi-disposable, flexible, and self-propelled endoscope for use in colonoscopy procedures, as well as ViRob, a revolutionary autonomous crawling micro-robot technology, which can be controlled remotely or within the body. Microbot Medical Inc. was founded in 2010 and is based in Yokneam, Israel.